Chemical stability of insulin. 1. Hydrolytic degradation during storage of pharmaceutical preparations.

J Brange, L Langkjaer, S Havelund, A Vølund
Author Information
  1. J Brange: Novo Research Institute, Bagsvaerd, Denmark.

Abstract

Hydrolysis of insulin has been studied during storage of various preparations at different temperatures. insulin deteriorates rapidly in acid solutions due to extensive deamidation at residue AsnA21. In neutral formulations deamidation takes place at residue AsnB3 at a substantially reduced rate under formation of a mixture of isoAsp and Asp derivatives. The rate of hydrolysis at B3 is independent of the strength of the preparation, and in most cases the species of insulin, but varies with storage temperature and formulation. Total transformation at B3 is considerably reduced when insulin is in the crystalline as compared to the amorphous or soluble state, indicating that formation of the rate-limiting cyclic imide decreases when the flexibility of the tertiary structure is reduced. Neutral solutions containing phenol showed reduced deamidation probably because of a stabilizing effect of phenol on the tertiary structure (alpha-helix formation) around the deamidating residue, resulting in a reduced probability for formation of the intermediate imide. The ratio of isoAsp/Asp derivative was independent of time and temperature, suggesting a pathway involving only intermediate imide formation, without any direct side-chain hydrolysis. However, increasing formation of Asp relative to isoAsp derivative was observed with decreasing flexibility of the insulin three-dimensional structure in the formulation. In certain crystalline suspensions a cleavage of the peptide bond A8-A9 was observed. Formation of this split product is species dependent: bovine greater than porcine greater than human insulin. The hydrolytic cleavage of the peptide backbone takes place only in preparations containing rhombohedral crystals in addition to free zinc ions.

References

  1. Nature. 1989 Apr 13;338(6216):594-6 [PMID: 2648161]
  2. Diabetes Care. 1991 Jan;14(1):42-8 [PMID: 1991434]
  3. Philos Trans R Soc Lond B Biol Sci. 1988 Jul 6;319(1195):369-456 [PMID: 2905485]
  4. Int J Pept Protein Res. 1986 Jul;28(1):79-84 [PMID: 3759344]
  5. Protein Eng. 1991 Feb;4(3):283-94 [PMID: 1649998]
  6. Diabetes. 1968 Aug;17(8):499-502 [PMID: 5668013]
  7. Biol Chem Hoppe Seyler. 1987 Aug;368(8):903-11 [PMID: 3311071]
  8. Diabetes. 1972 Jul;21(7):805-13 [PMID: 5039832]
  9. Science. 1988 Apr 8;240(4849):191-4 [PMID: 3353715]
  10. Pharm Res. 1990 Jun;7(6):593-9 [PMID: 2164192]
  11. J Biol Chem. 1988 Dec 15;263(35):19020-3 [PMID: 3198609]
  12. J Pharm Pharmacol. 1981 Apr;33(4):203-6 [PMID: 6115900]
  13. Diabetes. 1972 Apr;21(4):235-45 [PMID: 5017379]
  14. Curr Top Cell Regul. 1974;8(0):247-95 [PMID: 4371091]
  15. J Biol Chem. 1989 Apr 15;264(11):6164-70 [PMID: 2703484]
  16. Biochemistry. 1988 Oct 4;27(20):7671-7 [PMID: 3207697]
  17. Protein Eng. 1989 Jan;2(5):359-64 [PMID: 2494652]
  18. Diabet Med. 1986 Nov-Dec;3(6):532-6 [PMID: 2951208]
  19. J Biol Chem. 1962 Nov;237:3406-11 [PMID: 13979282]
  20. Diabetes. 1987 Jul;36(7):838-41 [PMID: 2438179]
  21. Biochemistry. 1963 Jan-Feb;2:22-8 [PMID: 13989254]
  22. Int J Pept Protein Res. 1987 Dec;30(6):808-21 [PMID: 3440704]
  23. Neth J Med. 1985;28 Suppl 1:43-6 [PMID: 3892338]
  24. Schweiz Med Wochenschr. 1969 Mar 22;99(12):414-20 [PMID: 5784012]
  25. Pharm Res. 1992 Jun;9(6):727-34 [PMID: 1409352]
  26. Methods Enzymol. 1977;47:132-45 [PMID: 927171]
  27. J Biol Chem. 1987 Jan 15;262(2):785-94 [PMID: 3805008]
  28. Pharm Res. 1989 Nov;6(11):903-18 [PMID: 2687836]

MeSH Term

Drug Stability
Drug Storage
Hydrolysis
Insulin
Models, Molecular
Temperature
Time Factors

Chemicals

Insulin

Word Cloud

Created with Highcharts 10.0.0insulinformationreducedstoragepreparationsdeamidationresidueimidestructuresolutionstakesplacerateisoAspAsphydrolysisB3independentspeciestemperatureformulationcrystallineflexibilitytertiarycontainingphenolintermediatederivativeobservedcleavagepeptidegreaterHydrolysisstudiedvariousdifferenttemperaturesInsulindeterioratesrapidlyaciddueextensiveAsnA21neutralformulationsAsnB3substantiallymixturederivativesstrengthpreparationcasesvariesTotaltransformationconsiderablycomparedamorphoussolublestateindicatingrate-limitingcyclicdecreasesNeutralshowedprobablystabilizingeffectalpha-helixarounddeamidatingresultingprobabilityratioisoAsp/Asptimesuggestingpathwayinvolvingwithoutdirectside-chainHoweverincreasingrelativedecreasingthree-dimensionalcertainsuspensionsbondA8-A9Formationsplitproductdependent:bovineporcinehumanhydrolyticbackbonerhombohedralcrystalsadditionfreezincionsChemicalstability1Hydrolyticdegradationpharmaceutical

Similar Articles

Cited By (34)